Integral Derivatives’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,400
Closed -$803K 730
2017
Q4
$803K Buy
+5,400
New +$735K 0.02% 558
2015
Q1
Sell
-35,900
Closed -$3.74M 1123
2014
Q4
$3.74M Buy
35,900
+6,200
+21% +$620K 0.06% 250
2014
Q3
$2.85M Buy
29,700
+9,100
+44% +$823K 0.05% 345
2014
Q2
$1.88M Buy
20,600
+12,600
+158% +$1.13M 0.03% 452
2014
Q1
$704K Sell
8,000
-16,900
-68% -$1.48M 0.01% 770
2013
Q4
$2.31M Buy
+24,900
New +$2.24M 0.03% 441

Other funds holding CLX

Integral Derivatives's CLX Position: Q3 2016 in Review

Integral Derivatives sold out of Clorox (CLX) in Q3 2016, closing a stake of 2,918 shares — an estimated $404K sold.

Integral Derivatives first reported a position in CLX in Q4 2014 and held it in 7 quarters. The position peaked at $2.31M in Q1 2016. 823 funds tracked by Wall St. Rank hold CLX as of Q3 2016.

  • Integral Derivatives reported no remaining Clorox position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 2,918 Clorox shares in Q3 2016, an estimated $404K.
  • Integral Derivatives first reported a position in Clorox in Q4 2014 and held it in 7 quarters.
  • Integral Derivatives's Clorox position peaked at $2.31M in Q1 2016.
  • 823 funds tracked by Wall St. Rank held Clorox as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.